# Nuvation Bio Inc.: Form 10-Q for the period ended Jun 30, 2021

- Company: [Nuvation Bio Inc.](/companies/nuvb.md) (CIK 1811063)
- Form: 10-Q
- Filed: 2021-08-12
- Accepted by EDGAR: Aug 12, 2021, 16:48 ET
- Period: 2021-06-30
- Accession: 0000950170-21-001385
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1811063/000095017021001385/nuvb-20210630.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1811063/000095017021001385/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 3 months, 2021-04-01 to 2021-06-30 | $14.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2021-01-01 to 2021-06-30 | $29.9m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2021-04-01 to 2021-06-30 | −$20.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2021-01-01 to 2021-06-30 | −$40.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2021-04-01 to 2021-06-30 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2021-01-01 to 2021-06-30 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2021-04-01 to 2021-06-30 | −$19.3m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2021-01-01 to 2021-06-30 | −$39.7m | us-gaap:NetIncomeLoss |
| Operating cash flow | 6 months, 2021-01-01 to 2021-06-30 | −$31.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2021-06-30 | $449.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-06-30 | $813.1m | us-gaap:AssetsCurrent |
| Total assets | at 2021-06-30 | $814.3m | us-gaap:Assets |
| Current liabilities | at 2021-06-30 | $10.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2021-06-30 | $25.3m | us-gaap:Liabilities |
| Shareholders' equity | at 2021-06-30 | $788.9m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1811063/000095017021001385/nuvb-20210630.htm

Filed Aug 12, 2021.
Source: SEC EDGAR, the filing index for accession 0000950170-21-001385. Last ingested by Listed: Nov 4, 2026, 17:21 ET. No prices; not investment advice.
